Clinical trialNCT06919354RecruitingPhase 1Interventional

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

SponsorGentiBio, IncEnrollment16Type 1 Diabetes (T1D)Type 1 Diabetes Mellitus

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Mark Bach, MD
GentiBio, Inc
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

City of Hope Medical Center
Duarte, California, United States
Recruiting
University of California - San Diego
San Diego, California, United States
Jeremy Pettus, MD
Recruiting
University of California - San Francisco
San Francisco, California, United States
Stephen Gitelman, MD
Recruiting
University of Florida - Gainesville
Gainesville, Florida, United States
Brittany Bruggeman, MD
Recruiting
University of Miami, Diabetes Research Institute
Miami, Florida, United States
Recruiting
Joslin Diabetes Center
Boston, Massachusetts, United States
Jason Gaglia, MD, MMSc
Recruiting
Columbia University
New York, New York, United States
Jacqueline Lonier, MD
Not, yet, recruiting
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Carol Levy, MD
Recruiting
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
John Buse, MD
Recruiting
Duke University
Durham, North Carolina, United States
Jennifer Green, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 3 Sept 2025
Primary completion: 29 Feb 2028
Completion: 29 Feb 2028
Last update posted: 4 May 2026
Registered enrollment: 16
Registry id: NCT06919354

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.